Clinical trial
Comparison of Lormetazepam and Midazolam Used as Sedatives for Patients That Require Intensive Care
NCT02022592 is registered in ClinicalTrials.gov with Claudia Spies as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Lormetazepam and Midazolam Used as Sedatives for Patients That Require Intensive Care
- Lead sponsor
- Claudia Spies
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 17, 2014
- Completion date
- March 12, 2020
- Enrollment
- 84 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
sedation in intensive care unit patients